Management of Pruritus After TIPS in Hepatic Encephalopathy
Treat post-TIPS pruritus as hepatic pruritus using rifampicin as first-line therapy, starting at 150 mg twice daily and titrating up to 600 mg twice daily as needed, while monitoring for hepatotoxicity. 1
Understanding the Clinical Context
Post-TIPS pruritus is not a commonly emphasized complication in TIPS guidelines, which focus primarily on hepatic encephalopathy (affecting one-third of patients) 2. However, when pruritus occurs in the setting of liver disease and portosystemic shunting, it should be approached as hepatic pruritus related to altered bile acid metabolism and hemodynamics.
Treatment Algorithm for Post-TIPS Pruritus
First-Line: Rifampicin
- Start with rifampicin 150 mg twice daily
- Titrate up to 600 mg twice daily based on response 1
- Monitor liver function tests for hepatotoxicity
- Inform patients about discoloration of secretions (urine, tears, sweat)
- Meta-analyses demonstrate rifampicin effectively reduces hepatic pruritus without increased side effects compared to placebo 1
Second-Line: Cholestyramine
- Use cholestyramine 9 g daily orally if rifampicin is contraindicated or ineffective 1
- Binds bile salts in the gut lumen, preventing absorption
- Common pitfall: Significant gastrointestinal side effects (constipation, diarrhea, abdominal pain, nausea) may limit tolerability
- Evidence is limited but supported by small RCTs 1
Third-Line: Sertraline
- Sertraline 75-100 mg daily for refractory cases 1
- Well-tolerated with RCT support for hepatic pruritus
- Preferred over opioid antagonists due to better side effect profile
Fourth-Line: Opioid Antagonists
- Naltrexone 50 mg daily or nalmefene (0.25-1 mg/kg/day IV) 1
- Warning: Significantly more side effects than other options, which may limit use
- Reserve for truly refractory cases
Critical Considerations Specific to TIPS Patients
Evaluate for Shunt-Related Issues
While not specifically addressing pruritus, if symptoms are severe and refractory:
- Consider whether excessive shunting is contributing to hepatic dysfunction
- In rare cases with intractable symptoms and preserved liver function, shunt embolization has been reported to normalize bile acids and resolve pruritus 3
- This is an extreme measure but demonstrates the shunt's potential role in symptom generation
Distinguish from Hepatic Encephalopathy Management
Do not confuse pruritus management with HE management:
- HE after TIPS is treated with lactulose (first-line) and rifaximin as add-on therapy 4
- For pruritus specifically, rifampicin is first-line, NOT rifaximin
- These are different medications with different mechanisms
Monitor Liver Function
- Post-TIPS patients already have compromised hepatic function
- Regular monitoring of bilirubin, transaminases, and synthetic function is essential
- Worsening liver function may necessitate reassessment of TIPS patency or consideration of transplant evaluation
What NOT to Use
- Gabapentin: Not recommended for hepatic pruritus 1
- Ondansetron: Conflicting evidence, difficult to support 1
- Antihistamines (diphenhydramine, hydroxyzine): Limited benefit as pruritus is not histamine-mediated 5
- Topical agents (menthol creams, calamine): Limited use due to widespread nature of hepatic pruritus 5
Key Pitfall to Avoid
Do not assume pruritus is simply part of HE or treat it with standard HE medications. Pruritus represents a distinct pathophysiologic process related to bile acid accumulation and requires specific antipruritic therapy with rifampicin as the evidence-based first choice.